SPHS - Sophiris Bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development10,7106,1863,5389,862
Selling General and Administrative4,4295,7326,7683,626
Non Recurring----
Total Operating Expenses15,13911,91810,30613,488
Operating Income or Loss-15,139-11,918-10,306-13,488
Income from Continuing Operations
Total Other Income/Expenses Net8,3613,290-858-709
Earnings Before Interest and Taxes-15,139-11,918-10,306-13,488
Interest Expense-684-207-373-690
Income Before Tax-6,778-8,628-11,164-14,197
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-6,778-8,628-11,164-14,197
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,778-8,628-11,164-14,197
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,778-8,628-11,164-14,197